Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
Sotio Biotech Inc.
Sotio Biotech Inc.
M.D. Anderson Cancer Center
Genmab
Ocellaris Pharma, Inc.
Seagen Inc.
Regeneron Pharmaceuticals
Transgene
Bolt Biotherapeutics, Inc.
NiKang Therapeutics, Inc.
MacroGenics
Numab Therapeutics AG
NuCana plc
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc.
Formation Biologics
M.D. Anderson Cancer Center
Numab Therapeutics AG
SK Life Science, Inc.
Kymab Limited
Seagen Inc.
Novartis
Novartis
Pfizer
Pfizer
ADC Therapeutics S.A.
Ikena Oncology
Gilead Sciences
Atreca, Inc.
Fate Therapeutics
Fate Therapeutics
Fred Hutchinson Cancer Center
Genmab
Genmab
Calithera Biosciences, Inc
Rubius Therapeutics
Fred Hutchinson Cancer Center
Gossamer Bio Inc.
Duke University
Incyte Corporation
Merck Sharp & Dohme LLC
Eli Lilly and Company
Pfizer
Tocagen Inc.
Celldex Therapeutics
AbbVie